Predicting the prevalence of antibody to hepatitis C virus (HCV) in a community by the prevalence of elevated levels of alanine aminotransferase: A method to identify areas endemic for HCV

American Journal of Tropical Medicine and Hygiene

Volumn 67, Issue 2 SUPPL., 2002, Pages 145-150

  Lu, Sheng Nan ^a   Wang, Jing Houng ^a   Kuo, Yung Kuang ^a   Kuo, Hsiu Lin ^a   Chen, Tsung Ming ^a   Tung, Hung Da ^a   Lee, Chuan Mo ^a   Chen, Shinn Chern ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTIC METHOD; ANTIBODY TITER; ARTICLE; COMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDEMIC DISEASE; ENZYME ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL EXAMINATION; PREDICTION; PREVALENCE; TAIWAN;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0036699418     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2002.67.145     Document Type: Article

References (36)

1. Chen DS, Sung JL, 1978. Hepatitis B virus infection and chronic liver diseases in Taiwan. Acta Hepatogastroenterol 25: 423-430.
2. Chen DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, Yang PM, Hsu HM, Chang MH, Chen CJ, 1990. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 162: 817-822.
3. Lee SD, Chan CY, Wang YJ, Wu JC, Lai KH, Tsai YT, Lo KJ, 1991. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 13: 830-833.
4. Lu SN, Chue PY, Chen HC, Wu MH, Chen IL, Huang JF, Wang JH, Peng CF, Shih CH, You SL, Lu CF, Chen CJ, Chang WY, 1997. Different viral etiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan. J Gastroenterol Hepatol 2: 547-550.
5. Chen IL, Lu SN, Wu CL, 1999. Anti-HCV prevalence among villages in an endemic township: a community study in Tzukuan, Kaohsiung. Chin J Public Health 18: 313-318.
6. Wang JH, Lu SN, Wu JC, Huang JF, Yu ML, Chen SC, Chuang WL, 1999. A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan. Trans R Soc Trop Med Hyg 93: 253-254.
7. Wang CS, Chang TT, Chou P, 1998. Differing characteristics of hepatitis B and C risk factors among the elderly in a rural area in Taiwan. J Gerontol A Biol Sci Med Sci 53: M107-111.
8. Ho MS, Hsu CP, Yuh Y, King CC, Tsai JF, Mau YC, Hsu LC, Chao WH, 1997. High rate of hepatitis C infection in an isolated community: persistent hyperendemicity or period-related phenomena? J Med Virol 52: 370-376.
9. Chang SJ, Chen HC, Ying J, Lu CF, Ko YC, 1996. Risk factors of hepatitis C virus infection in a Taiwanese aboriginal community. Kaohsiung J Med Sci 12: 241-247.
10. Lu SN, Chue PY, Chen IL, Wang JH, Huang JF, Peng CF, Shih CH, Chang WY, 1997. Incidence of hepatitis C endemic town-ship in southern Taiwan. Kaohsiung J Med Sci 13: 605-608.
11. Sun CA, Chen HC, Lu SN, Chen CJ, Lu CF, You SL, Lin SH, 2001. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol 65: 30-34.
12. Kiyosawa K, Tanaka E, Sodeyam T, Yoshizawa K, Yabu K, Furuta K, Imai H, Nakano Y, Usuda S, Uemura K, 1994. Transmission of hepatitis C in an isolated area in Japan: community-acquired Infection. Gastroenterology 106: 1596-1602.
13. Ohshima S, Komatsu M, Nakane K, Meng XW, Goto T, Fujii T, Yoneyama K, Wada Y, Tobori F, Mukaide M, Masamune O, Watanabe S, 2000. Iatrogenic GB virus C/hepatitis G virus infection in an area endemic for hepatitis C virus. J Hosp Infect 44: 179-185.
14. Chang WY, Chen CJ, Lu SN, You SL, Chuang WL, Chen SC, Su WP, Wang LY, Hsieh MY, Wu MM, Tai TY, 1992. Relationship between fatty liver, alanine aminotransferase, HBsAg and hepatitis C virus. J Gastroenterol Hepatol 7: 455-458.
15. Chen DS, 1993. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 262: 369-370.
16. Chen CJ, Lu SN, You SL, Wu MH, Wang LY, Lee LT, Huang GT, Yang PM, Lee HS, Lo CS, Chen CT, Ho SC, Lee CT, Lin CG, O YC, 1995. Community-based hepatocellular carcinoma screening in seven townships in Taiwan. J Formos Med Assoc 94: s94-s102.
17. Sun CA, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, Hardy W, Huang GT, Yang PM, Lee HS, Chen CJ, 1996. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infection in hepatocellular carcinogenesis: a population-based case-control study in Taiwan. Cancer Epidemiol Biomarkers Prev 5: 173-178.
18. Lu SN, Lin TM, Chen CJ, Chen JS, Liaw YF, Chang WY, Hsu ST, 1988. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 62: 2051-2055.
19. Chen CJ, Liang KY, Chang AS, Chang YC, Lu SN, Liaw YF, Chang WY, Sheen MC, Lin TM, 1991. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 13: 398-406.
20. Chuang WL, Chang WY, Lu SN, Su WP, Lin ZY, Chen SC, Hsieh MY, Wang LY, You SL, Chen CJ, 1992. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer 69: 2052-2054.
21. Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ, 1991. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 51: 5621-5625.
22. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, Chen DS, 1996. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 276: 906-908.
23. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS, 1997. Universal hepatitis B vaccination in Taiwan and incidence of hepatoma in children. N Engl J Med 336: 1855-1859.
24. Lee CL, Ko YC, 1997. Hepatitis B vaccination and hepatocellular carcinoma in Taiwan. Pediatrics 99: 351-353.
25. Kuo G, Choo QL, Alter HJ, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362-364.
26. Williams I, 1999. Epidemiology of hepatitis C in the United States. Am J Med 107: 2S-9S.
27. Chang TT, Young KC, Yang YJ, Lai KA, Wu HL, Wu MH, Chen MY, Lin XZ, Lin CY, Shin JS, 1996. Incidence of posttransfusion hepatitis in Taiwan before and after introduction of anti-HCV testing. Liver 16: 201-206.
28. Mansell CJ, Locarnini SA, 1995. Epidemiology of hepatitis C in the east. Semin Liver Dis 15: 15-32.
29. Arthur RR, Hassan NF, Abdallah MY, el-Sharkawy MS, Saad MD, Hackbart BG, Imam IZ, 1997. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans R Soc Trop Med Hyg 91: 271-274.
30. Lee CM, Lu SN, Changchien CS, Yeh CT, Hsu TT, Tang JH, Wang JH, Lin DY, Chen CL, Chen WJ, 1999. Age, gender and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 86: 1143-1150.
31. Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, Teratani T, Tohgo G, Toda N, Ohashi M, 1995. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology 22: 1027-1033.
32. Lam NP, 1999. Hepatitis C: natural history, diagnosis, and management. Am J Health Syst Pharm 56: 961-973.
33. Wang JH, Lu SN, Hsu CT, 1998. Hepatitis C is one major viral etiology of hepatocellular carcinoma in Chiayi and Yingling. J Int Med Taiwan 9: 120-125.
34. Lu SN, Lee CM, Chanhchien CS, Chen CJ, 1999. Excess mortality from hepatocellular carcinoma in an HCV-endemic township of an HBV-endemic country. Trans R Soc Trop Med Hyg 93:600-602.
35. Lu SN, Chen HC, Tang CM, Wu MH, Yu ML, Chunag WL, Lu CF, Chang WL, Chen CJ, 1998. Prevalence and manifestation of hepatitis C seropositivity in children in an endemic area. Pediatr Infect Dis J 17: 142-145.
36. Huang JF, Lu SN, Chue PY, Lee CM, Yu ML, Chuang WL, Wang JH, Dai CY, Chen IL, Shih CH, Chang WY, 2001. Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies. Epidemiol Infect 127: 485-492.